Bovine-based Collagen for Biomedical Application Market Analysis

Based on application, the market is segmented into wound dressing, bone graft substitute, collagen-based scaffold, hemostat, skin substitute, cartilage repair, and other applications. The wound dressing segment held the majority of market share in 2023 of about 28.4%.

• The dominating share of wound dressing segment can be attributed to an increasing adoption of hydrolyzed bovine-collagen products in wound care dressings. According to a study published by National Center for Biotechnology Information, hydrolyzed collagen powder favorably influences both wound inflammation and vascularization. As a result, the demand for bovine-based collagen is increasing in wound healing applications.
  
• Additionally, increasing use of bovine-collagen products in the treatment of chronic wounds is also driving the revenue growth in the segment. According to an April 2024 article published by ResearchGate, chronic wounds affected about 1-2% of population in developed countries in 2019. High prevalence of chronic wounds is driving the adoption of bovine-collagen in wound dressing.
  

Based on distribution channel, the bovine-based collagen for biomedical application market is classified into hospital pharmacies and retail pharmacies. The hospital pharmacies segment dominated the market with a revenue of about USD 641.4 million in 2023.

• Leading share of hospital pharmacies segment can be attributed to their direct access for patients who are admitted for treatment or are undergoing surgical interventions, allowing them to dispense bovine-based collagen products efficiently.
  
• Moreover, bovine-based collagen products are often used in specialized medical applications such as wound dressing, surgical procedures, and tissue engineering. These applications require specialized knowledge and expertise typically found in hospital settings, which contributes to the overall growth of the segment.
  

North America bovine-based collagen for biomedical application market accounted for 42.1% of market share in global market in 2023 and is predicted to reach USD 966.8 million by 2032.

• Leading share of North America can be attributed to the presence of many leading manufacturers and suppliers of bovine collagen products that have a significant presence in the region. These companies benefit from the region's robust healthcare ecosystem and access to skilled labor and resources.
  
• Moreover, increasing investments in biomedical research in the U.S. is facilitating research and academic institutes in developing an advanced biomedical product such as bovine-based collagen. According to the Department of Health and Human Services, the R&D expenditures in the U.S. increased in biological and biomedical sciences by about USD 1.6 billion during 2020-2022, contributing to an overall revenue growth in the market in the region.
  

The U.S. bovine-based collagen for biomedical application market was valued at USD 381.6 million in 2023 and is anticipated to grow at a CAGR of 9.5% over the forecast period.

• Increasing awareness for the application of bovine-based collagen products in wound dressing, surgery, and bone grafting is driving the demand for these products, contributing to an increased revenue growth in the country.  
  
• Furthermore, presence of large number of vendors offering advanced tissue engineered products, bovine collagen-based hemostats, and scaffolds are supplementing the revenue growth of the market in the U.S.   
  

Germany bovine-based collagen for biomedical application market is expected to show significant growth opportunities during the forecast period.

• Presence of large number of companies offering advanced biomedical products is driving the demand for bovine-based collagen for biomedical applications. According to the Germany Trade & Invest, in 2021, there were about 774 biotechnology companies in Germany offering advanced biomedical products.
  
• Moreover, growing awareness in Germany towards advanced therapeutic options including the bovine collagen-based therapeutic products in wound healing and cartilage repair is also fueling the revenue growth in the market. Organizations such as European Wound Management Association are contributing to increasing awareness about wounds and wound care management in Germany, paving the way for increasing adoption of bovine collagen-based wound dressing products.
  

India bovine-based collagen for biomedical application market is anticipated to grow remarkably over the coming years.

• Increasing research for development activities dedicated to commercializing bovine collagen-based products in India is easing their availability, contributing to the overall market growth in the country. For instance, in September 2022, Central Leather Research Institute received a patent for their newly developed collagen sheet for wound dressing.
  
• Furthermore, increasing demand for chronic wound therapy is also driving the adoption of bovine-collagen across healthcare settings in India. According to a 2023 study published by ScienceDirect, about 15-20% of population with diabetes are affected with diabetic foot ulcer, a chronic wound. Owing to high prevalence of chronic wounds, the demand for their effective treatment has increased, fueling the demand for bovine collagen-based products in wound dressings.